Analysts Initiate Coverage on Three Biotech and Aerospace Stocks
Mizuho, Roth Capital, and an unnamed GE Aerospace analyst started coverage on Century Therapeutics, BioAge Labs, and GE Aerospace with positive ratings and price targets.
BenzingaMizuho analyst Salim Syed began coverage of Century Therapeutics Inc with an Outperform rating and an $8 price target. 17 on Tuesday. Roth Capital analyst Adam Walsh started coverage of BioAge Labs Inc with a Buy rating and a $36 price target.
A GE Aerospace analyst also initiated coverage on a bullish note, according to the report. The initiations form part of a broader set of analyst rating changes released on Wednesday.
Transparency
Reported by a single outlet. This score reflects source tier and factual specificity — corroboration is limited with one source.
Story details
Related Stories
Substrate placeholder — needs reviewIran Suspends Indirect Talks With U.S. Amid Escalating Israel-Hezbollah Conflict in Lebanon
Iran has stopped all message exchange with the United States, including ongoing talks, in response to Israel's expanded offensive in Lebanon. The suspension was reported by Tasnim News Agency, which is affiliated with the Islamic Revolutionary Guard Corps according to the Jerusal…
france24.comIranian Official: Tehran Manages Strait of Hormuz and Will Not Allow Maritime Blockade
Mohsen Rezaei stated that Iran controls the Strait of Hormuz and will not allow a maritime blockade to continue. Oil prices rose 8 percent on the day of the statements.
Al JazeeraGreece Reviews Asylum Status for Syrians and Afghans After Conflicts End
Greek authorities began reviewing protection status for Syrians and Afghans in February after the end of Syria's civil war and the 2021 Taliban takeover. The reviews target men and coincide with new returns legislation.